TY - JOUR T1 - Emergency treatment of anaphylaxis: concise clinical guidance JF - Clinical Medicine JO - Clin Med SP - 332 LP - 339 DO - 10.7861/clinmed.2022-0073 VL - 22 IS - 4 AU - Andrew F Whyte AU - Jasmeet Soar AU - Amy Dodd AU - Anna Hughes AU - Nicholas Sargant AU - Paul J Turner Y1 - 2022/07/01 UR - http://www.rcpjournals.org/content/22/4/332.abstract N2 - Anaphylaxis is a serious systemic hypersensitivity reaction that is usually rapid in onset and may cause death. It is characterised by the rapid development of airway and/or breathing and/or circulation problems. Intramuscular adrenaline is the most important treatment, although, even in healthcare settings, many patients do not receive this intervention contrary to guidelines. The Resuscitation Council UK published an updated guideline in 2021 with some significant changes in recognition, management, observation and follow-up of patients with anaphylaxis. This is a concise version of the updated guideline. ER -